Disturbance of posture in children with very low lead exposure, and modification by VDR FokI genotype
More details
Hide details
Institute of Occupational Medicine and Environmental Health, Sosnowiec, Poland
Division of Occupational and Environmental Medicine, Department of Laboratory Medicine, Lund, Sweden
Department of Hygiene, Wroclaw Medical University, Wroclaw, Poland
Ann Agric Environ Med 2014;21(4):739–744
Introduction and objective:
Lead has a negative effect on the central nervous system (CNS), [i]inter alia [/i]indicated by disturbance of posture. However, knowledge of the CNS effects at low exposure is insufficient. Individuals differ in vulnerability, possibly because of genetic predisposition. Polymorphisms in the δ-aminolevulinic acid dehydratase (ALAD) and vitamin D receptor (VDR) genes may modify lead metabolism and neurotoxicity. The objective of the study was to determine whether very low lead exposure affects posture in children, and whether ALAD and VDR genotypes modify the effect.

Material and Methods:
In 1996–2001, 108 (age 5–13, mean 6.9), and in 2008–2010 231 (age 5–11, mean 7.9) children from Poland were tested by posturography and blood-lead concentration (B-Pb; medians 50 and 36 µg/L, respectively). The children were genotyped for ALAD (RsaI, MspI) and VDR (FokI, BsmI, TaqI).

There were correlations between posture and B-Pb (sway area with closed eyes: rS=0.24, P<0.001; velocity: rS=0.21, P<0.001). Significant effects (adjusted for the potential confounders height and mother´s education) were present already at (ln-transformed) B-Pb<50 µg/L [β (regression coefficient) for sway area 0.025, p=0.001), and even stronger than at higher levels (β=0.006, p=0.06, respectively)]. The ff carriers in VDR FokI polymorphism were more susceptible to the effect of lead on the balance system, while other VDR or ALAD genotypes did not significantly modify the effect.

Effects on CNS, as reflected by disturbances of posture, were present at very low lead exposure (B-Pb<50 µg/L), and the effect was significantly greater at such low B-Pbs than at higher. VDR FokI significantly modified the effect.

1. Bhattacharaya A. Quantitative posturography as an early monitoring tool for chemical toxicity. In: Quehee S. Biological Monitoring An Introduction, John Wiley & Sons Inc. 1993.p. 421–435.
2. Bhattacharaya A, Shukla R, Auyang ED, Dietrick KN, Bornschein R. Effect of succimer chelation therapy on postural balance and gait outcomes in children with early exposure to environmental lead. Neurotoxicology 2007; 28: 686–695.
3. Després C, Beuter A, Richer F, Poitras K, Veilleux A, Ayotte P, et al. Neuromotor functions in Inuit preschool children exposed to Pb, PCB and Hg. Neurotoxicol Teratol. 2005; 27: 245–257.
4. Frazer S, Muckle G, Després C. The relationship between lead exposure, motor function and behaviour in Inuit preschool children. Neurotoxicol Teratol. 2006; 28: 18–27.
5. Pawlas K, Pawlas N, Kmiecik-Malecka E, Malecki A. The relationship between children´s blood lead level and postural stability. J Hum Kinetics. 2008; 20: 71–80.
6. Hruba F, Stromberg U, Cerna M, Chen C, Harari F, Harari R, et al. Blood cadmium, mercury, and lead in children: An international comparison of cities in six European countries, and China, Ecuador, and Morocco. Environment International. 2012; 41: 29–34.
7. Finkelstein Y, Markowitz ME, Rosen JF. Low-level lead-induced neurotoxicity in children: an update on central nervous system effects. Brain Res Rev. 1998; 27: 168–176.
8. Toscano CD, Guilarte TR. Lead neurotoxicity: from exposure to molecular effects. Brain Res Rev. 2005; 49: 529–554.
9. Caylak E, Halifeoglu I, Aydin S, Telo S, Bulmus O, Celik H. The effects of sulfur-containing compounds on total antioxidant capacity levels of liver, kidney and brain in lead-exposed rats. Turkiye Klinikleri Journal of Medical Sciences. 2007; 27: 823–828.
10. Nordberg GF, Gerhardsson L, Broberg K, Mumtaz M, Ruiz P, Fowler BA. Chapter 7. Interactions in Metal Toxicology. In: Nordberg GF, Fowler BA, Nordberg M, Friberg LT. Handbook on the Toxicology of Metals. Academic Press, Elsevier, 2007.p. 117–145.
11. Scinicariello F, Murray HE, Moffett DB, Abadin HG, Sexton MJ. Lead and -aminolevulic acid dehydratase polymorpshism: Where does it lead? A meta-analysis. Environ Health Perspect. 2007; 115: 35–41.
12. Zhao Y, Wang L, Shen HB, Wang ZX, Wei QY, Chen F. Association between delta-aminolevulinic acid dehydratase (ALAD) polymorphism and blood lead levels: a meta-regression analysis. J Toxicol Environ Health A. 2007; 70: 1986–1994.
13. Zheng G, Tian L, Liang Y, Broberg K, Lei L, Guo W, et al. δ-aminolevulinic acid dehydratase genotype predicts toxic effects of lead on worker´s peripheral nervous system. Neurotoxicology 2011; 32: 374–382.
14. Pawlas N, Broberg K, Olewińska E, Prokopowicz A, Skerfving S, Pawlas K. Modification by the genes ALAD and VDR of lead-induced cognitive effects in children. Neurotoxicology 2012; 33: 37–43.
15. Weuve J, Kelsey KT, Schwartz J, Bellinger D, Wright RO, Rajan P, et al. Delta-aminolevulinic acid dehydratase polymorphism and the relation between low level lead exposure and the Mini-Mental Status Examination in older men: the Normative Aging Study. Occup Environ Med. 2006; 63: 746–53.
16. Chia SE, Huijun Z, Theng TM , Yap E. Possibilities of newer ALAD polymorphism influencing human susceptibility to effects of inorganic lead on the neurobehavioral functions. Neurotoxicology. 2007; 28: 312–317.
17. Krieg EF Jr, Butler MA, Chang MH, Liu T, Yesupriya A, Lindegren ML, et al. Lead and cognitive function in ALAD genotypes in the third National Health and Nutrition Examination Survey. Neurotoxicol Teratol. 2009; 31: 364–371.
18. Gao A, Lu XT, Li QY, Tian L. Effect of the delta-aminolevulinic acid dehydratase gene polymorphism on renal and neurobehavioral function in workers exposed to lead in China. Sci Tot Environ. 2010; 408: 4052–4055.
19. Rezende VB, Barbosa F Jr, Montenegro MF, Sandrim VC, Gerlach RF, Tanus-Santos JE. Haplotypes of vitamin D receptor modulate the circulating levels of lead in exposed subjects. Arch Toxicol. 2008; 82: 29–36.
20. Schwartz BS, Lee BK, Lee GS, Stewart WF, Simon D, Kelsey K, et al. Associations of blood lead, dimercaptosuccinic acid chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes. Environ Health Perspect. 2000; 108: 949–954.
21. Haynes EN, Kalkwarf HJ, Hornung R, Wenstrup R, Dietrich K, Lanphear BP. Vitamin D receptor Fok1 polymorphism and blood lead concentration in children. Environ Health Perspect. 2003; 111: 1665–1669.
22. Krieg EF Jr, Butler MA, Chang MH, Liu T, Yesupriya A, Dowling N, et al. Lead and cognitive function in VDR genotypes in the third National Health and Nutrition Examination Survey. Neurotoxicol Teratol. 2010; 32: 262–272.
23. Deprés C, Lamoureux D, Beuter A. Standardization of a neuromotor test battery: the CATSYS system. Neurotoxicology 2000; 21: 725–35.
24. Stoeppler M, Brandt K, Rains TC. Contribution to automated trace analysis. Part II. Rapid method for the automated determination of lead in whole blood by electrothermal atomic-absorption spectrophotometry. Analyst. 1978; 103: 714–722.
25. Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, et al. Low-level environmental lead exposure and children’s intellectual function: an international pooled analysis. Environ Health Perspect. 2005; 113: 894–899.
26. Chakraborty BM, Lee HS, Wolujewicz M, Mallik J, Sun G, Dietrich KN, et al. Low dose effect of chronic lead exposure on neuromotor response impairment in children is moderated by genetic polymorphisms. J Hum Ecol. 2008; 23: 183–194.
27. Ratzon N, Froom P, Leikin E, Kristal-Boneh E, Ribak J. Effect of exposure to lead on postural control in workers. Occup Environ Med. 2000; 57: 201–203.
28. Uitterlinden AG, Fang Y, van Meurs JBJ, Pols HAP, van Leeuwen JPTM. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338: 143–156.
29. (access: 2013.04.03).